150 related articles for article (PubMed ID: 18971983)
1. Alzheimer's tests under fire.
Hayden EC
Nature; 2008 Oct; 455(7217):1155. PubMed ID: 18971983
[No Abstract] [Full Text] [Related]
2. Apolipoprotein E genotyping for Alzheimer's disease: ethical concerns and implications for clinical practice.
Abyad A; al Imad R
J Med Liban; 1999; 47(5):291-4. PubMed ID: 10887530
[No Abstract] [Full Text] [Related]
3. Apolipoprotein E genotyping in Alzheimer's disease. The UK Alzheimer's Disease Genetic consortium.
Lovestone S; Wilcock G; Rossor M; Cayton H; Ragan I
Lancet; 1996 Jun; 347(9017):1775-6. PubMed ID: 8656944
[No Abstract] [Full Text] [Related]
4. Alzheimer's disease: recent progress and prospects--Part I.
Harv Ment Health Lett; 2001 Oct; 18(4):1-4. PubMed ID: 11684504
[No Abstract] [Full Text] [Related]
5. Genetic variation at a single locus and age of onset for Alzheimer's disease.
Lutz MW; Crenshaw DG; Saunders AM; Roses AD
Alzheimers Dement; 2010 Mar; 6(2):125-31. PubMed ID: 20298972
[TBL] [Abstract][Full Text] [Related]
6. Medicolegal, employment, and insurance issues in APOE genotyping and Alzheimer's disease.
Kapp MB
Ann N Y Acad Sci; 1996 Dec; 802():139-48. PubMed ID: 8993493
[No Abstract] [Full Text] [Related]
7. Apolipoprotein E and the neuropathology of Alzheimer's disease.
Mirra SS
Hum Pathol; 1999 Oct; 30(10):1125-7. PubMed ID: 10534156
[No Abstract] [Full Text] [Related]
8. Apolipoprotein E Genotyping in Alzheimer's Disease. Chicago, Illinois, October 21-22, 1995. Proceedings.
Ann N Y Acad Sci; 1996 Dec; 802():1-224. PubMed ID: 9012314
[No Abstract] [Full Text] [Related]
9. NIA/AIzA Conference on apolipoprotein E genotyping in Alzheimer's disease. Bibliography.
Kwon YJ; Tsai J; Relkin NR
Ann N Y Acad Sci; 1996 Dec; 802():177-224. PubMed ID: 9012315
[No Abstract] [Full Text] [Related]
10. Apolipoprotein E genotyping in Alzheimer's disease.
Humphries S; Betteridge DJ; Durrington PN; Galton DJ; Nicholls P
Lancet; 1996 Jun; 347(9017):1776. PubMed ID: 8656945
[No Abstract] [Full Text] [Related]
11. Alzheimer's (AD).
J Pract Nurs; 2009; 59(2):5-7. PubMed ID: 19718998
[No Abstract] [Full Text] [Related]
12. Genetic testing and Alzheimer's disease.
Health News; 1998 Mar; 4(4):5. PubMed ID: 9553608
[No Abstract] [Full Text] [Related]
13. Genetic discoveries as the basis of personalized therapy: rosiglitazone treatment of Alzheimer's disease.
Hsueh W
Pharmacogenomics J; 2006; 6(4):222-4. PubMed ID: 16865098
[No Abstract] [Full Text] [Related]
14. Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer's disease.
Poirier J
Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S91-7. PubMed ID: 18632009
[No Abstract] [Full Text] [Related]
15. Limitations of using the apolipoprotein E genotype in the diagnosis of Alzheimer's disease.
Heidenreich W
J Insur Med; 1998; 30(1):46-7. PubMed ID: 10186439
[No Abstract] [Full Text] [Related]
16. Molecular genetics of Alzheimer's disease and aging.
Cacabelos R; Fernandez-Novoa L; Lombardi V; Kubota Y; Takeda M
Methods Find Exp Clin Pharmacol; 2005 Jul; 27 Suppl A():1-573. PubMed ID: 16470248
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease.
Roses AD
Ann Neurol; 1995 Jul; 38(1):6-14. PubMed ID: 7611727
[No Abstract] [Full Text] [Related]
18. Testing for Alzheimer's.
Merz JF; Cho MK
Science; 1998 Aug; 281(5381):1288-9. PubMed ID: 9735044
[No Abstract] [Full Text] [Related]
19. Alzheimer's disease: the genetics of risk.
Roses AD
Hosp Pract (1995); 1997 Jul; 32(7):51-5, 58-63, 67-9. PubMed ID: 9227658
[TBL] [Abstract][Full Text] [Related]
20. Early-onset Alzheimer disease: when is genetic testing appropriate?
Goldman JS; Hou CE
Alzheimer Dis Assoc Disord; 2004; 18(2):65-7. PubMed ID: 15249849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
